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Atomic Resolution Structure of Moloney Murine
Leukemia Virus Matrix Protein and Its
Relationship to Other Retroviral Matrix Proteins
invariant order, encoding the structural, enzymatic, and
envelope proteins, respectively (for review see [2]). The
gag gene product is a polyprotein precursor (Pr65gag),
which comprises four proteins, termed matrix (MA), p12,
capsid (CA), and nucleocapsid (NC). It is a widely used
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gene therapy.Roosevelt Drive
Oxford OX3 7BN The matrix protein undergoes cotranslational myristoy-
lation at the glycine residue, which becomes N-terminalUnited Kingdom
2 Department of Biochemistry after the removal of the first methionine residue [3]. As in
most C-type retroviruses, the Gag polyprotein of M-MuLVSouth Parks Road
Oxford OX1 3QU is then efficiently targeted to the plasma membrane of
the host cell [3, 4], where particle formation and buddingUnited Kingdom
3 Laboratory of Structural Biology occur simultaneously [5, 6]. After budding, immature
C-type viral particles appear hollow. Further drasticSchool of Life Science and Engineering
Tsinghua University structural changes then occur that convert the immature
viral particle into an infectious form. This process,Beijing 100084
China termed maturation, comprises the proteolysis of the Gag
precursor, rearrangement of the separated elements,4 Oxford Centre for Molecular Sciences
South Parks Road and condensation of the core forming the mature virion.
Electron microscopy of immature HIV-1 particles revealsOxford OX1 3QT
United Kingdom concentric high-density layers under the membrane bi-
layer. These layers have been interpreted as fully folded
single-matrix domains, two capsid domains and a single
nucleocapsid domain, creating special structural “lay-Summary
ers” via lateral interactions and connected to each other
by flexible uncleaved “bridges” of Gag [7].Matrix proteins associated with the viral membrane
Factors other than myristate have been shown, inare important in the formation of the viral particle and
other matrix proteins, to increase membrane bindingin virus maturation. The 1.0 A˚ crystal structure of the
energy. For example, electrostatic interaction of a clus-ecotropic Gammaretrovirus Moloney murine leukemia
ter of basic residues with the acidic phospholipids ofvirus (M-MuLV) matrix protein reveals the conserved
the plasma membrane has been shown to contribute totopology of other retroviral matrix proteins, despite
membrane binding energy in an additive manner (re-undetectable sequence similarity. The N terminus
viewed in [8]). Other functions have been attributed to(normally myristylated) is exposed and adjacent to a
the MA region, in addition to its central role in promotingbasic surface patch, features likely to contribute to
an interaction with the plasma membrane. For example,membrane binding. The four proteins in the asymmet-
for HIV-1, MA plays a role in the incorporation of theric unit make varied contacts. The M-MuLV matrix
viral envelope protein into the developing particle [8–10],structure is intermediate, between those of the lentivi-
as well as in early postentry events of the viral life cycleruses and other retroviruses. The protein fold appears
[11], nuclear targeting of the viral preintegration complexto be maintained, in part, by the conservation of side
[12–16], and particle assembly and budding through thechain packing, which may provide a useful tool for
formation of MA-MA multimers [17].searching for weak distant similarities in proteins.
Several matrix protein structures have been deter-
mined by X-ray and/or NMR techniques. These include
Introduction representatives from the Lentivirinae subfamily, e.g.,
simian immunodeficiency virus (SIV) [18], human immu-
Moloney murine leukemia virus (M-MuLV) is classified nodeficiency virus (HIV-1) [19–21], and equine infectious
into the subfamily Orthoretrovirinae of the family Retro- anemia virus (EIAV) [22], the Alpharetroviruses, e.g.,
viridae, genus Gammaretrovirus (more commonly de- avian C-type [23], the Betaretroviruses, e.g., Mason-
scribed according to its former classification to the Pfizer monkey virus (MPMV)[24], and the Deltaretrovi-
mammalian C-type group of the Oncovirinae). The Molo- ruses, e.g., human T cell leukemia virus (HTLV) [25] and
ney form induces T lymphoma in mice [1] and has pro- bovine leukemia virus (BLV) [26]. M-MuLV MA protein
vided significant insights into the role of activated pro- has low sequence identity with other matrix proteins
tooncogenes in tumorigenesis. and has a high proportion of prolines. Here we describe
M-MuLV is a very simple retrovirus, yet it retains all the the three-dimensional structure of M-MuLV MA, which
typical features. It is enveloped and contains positive- reveals a striking conservation in overall topology and
strand RNA, bearing three genes (gag, pol, and env) in
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Table 1. Structure Determination
MFID (%)b FH/Eh
Number of Unique Reflections
Data Set dmax (Outer Shell) (A˚) I/Ia (Outer Shell) Rmerge (%)g (% Completeness) N-1 N-2 Isomorphous Anomalous
N-1 2.00 (2.03–2.00) 19.7 (6.2) 7.3 19,617 (85) — 17 — —
N-2 1.00 (1.04–1.00) 18.1 (0.9) 6.2 141,760 (86) 17 — — —
EMPc 2.10 (2.15–2.10) 20.9 (4.1) 7.6 16,737 (96) 14 22 1.4 0.9
mHgd 2.80 (2.86–2.8) 17.9 (8.9) 7.9 7,427 (97) 22 20 1.7 1.3
HgIe 2.29 (2.37–2.29) 28.1 (6.5) 7.5 13,222 (97) 21 27 0.6 0.7
PtClf 2.08 (2.15–2.08) 31.3 (11.4) 4.6 17,897 (95) 24 22 1.4 1.7
aI/I, numbers calculated with SCALEPACK [37].
b The mean fractional isomorphous difference (MFID) was calculated with SCALEIT [38].
c EMP, crystals were soaked in 5 mM ethyl-mercury-phosphate for 22 hr.
d mHg, crystals were soaked in 10 mM methyl-mercury-chloride for 3 days.
e HgI, crystals were soaked in 0.5 mM K2HgI4/2.5 mM KI for 6 hr.
f PtCL, crystals were soaked in 10 mM K2PtCl4 for 27.5 hr.
g Rmerge  100  hj||Ih, merged|  |Ih, j||/hN|Ih, merged|, where j  1, …, n for n data sets.
h SHARP [40] was only used for phase calculation of native 1 (N-1). FH/E, the phasing power is the rms value of FH divided by the rms
lack of closure error. The figure of merit (the cosine of the mean phase error) was 0.55.
the pattern of secondary structural units, indicative of the molecule is mostly hydrophobic, with scattered
small charged regions, but not strikingly bipartite, asthe biological relevance of this structure. We also de-
scribe a method for structure-based phylogeny and has been visualized for SIV [18] and HIV-1 [19]. The N
terminus of helix 2 is stabilized by a stacking interactionshow that analysis of core packing in proteins might
provide a sensitive tool to detect distant homologies. between Trp35 and Trp86 (helix 4), while, at the end of
helix 2, a 310 helix is found (residues 43–46). Trp43 is
hydrogen bonded to Gln79 and Pro44. Gln 79 terminatesResults and Discussion
the 310 helix located at the N terminus of helix 4 (residues
77–79). Pro71-Gly72-Pro73 form a sharp turn betweenStructure Determination
helices 3 and 4. Helix 4 traverses the protein, creatingThe C-terminally truncated, 100-residue MA protein
a stabilizing column by carrying large hydrophobic resi-from M-MuLV was expressed in E. coli (hence, without
dues. Prolines 77 and 81 are located toward the N termi-any N-terminal myristic acid modification [see Experi-
nus of this helix. Three prolines, 93–95, stabilize themental Procedures]). Crystals were obtained that be-
C-terminal “tail” region. The only cysteine (Cys39) islonged to spacegroup P1, with four molecules in the
located deep inside the protein structure and sur-asymmetric unit. The structure was solved by multiple
rounded by three tryptophans (Trp43, Trp50, and Trp86).isomorphous replacement with four derivatives, to-
gether with solvent flattening and averaging (Table 1).
The final model was refined against data extending to Organization of Subunits in the Crystal
1.0 A˚ resolution, with the electron density being, as ex- The arrangement of the subunits within the asymmetric
pected, of high quality. This represents the most precise unit is shown in Figure 1B. Very crudely, the arrangement
analysis of a viral matrix protein to date (Figure 1). shows 222 symmetry, with two monomers (henceforth
referred to as monomers 3 and 4) forming a dimer and
the remaining two monomers (1 and 2) forming aSubunit Structure
The protein, a helical bundle, comprises five  helices pseudodimer (superimposition of the latter requires a
179	 rotation). These two dimers are then roughly related(1a, 1b, 2, 3, and 4), so numbered because they corre-
spond to the first four helices observed in other matrix to each other by a 2-fold axis. The extent of interaction
between the various pairs of subunits can be quantifiedproteins, and two 310 helices (Figures 2A and 2B). Ne-
glecting the N-terminal extension, the molecule is wedge by buried surface area calculations [27]. These reveal
buried surface areas of 1126 A˚2 between monomers 1shaped, with overall dimensions of 38  28  21 A˚3.
The first eight residues are exposed, perpendicular to and 2, 118 A˚2 between monomers 1 and 3, 1188 A˚2
between monomers 1 and 4, 934 A˚2 between monomersthe rest of the protein (Figures 2A and 2B). This presenta-
tion is mediated by Pro8, which forms a sharp bend at 2 and 3, and 477 A˚2 between monomers 3 and 4 (mono-
mers 2 and 4 do not interact). Overall the associationsthe beginning of helix 1a, making a stacking interaction
with Phe56. Helices 1a and 1b are divided by an abrupt between subunits of M-MuLV MA appear to be quite
pleiomorphic.bend between residues 15 and 16 (His15 makes a stack-
ing interaction with Trp96). Helix 1b is further stabilized A superimposition of all four monomers (Figure 1C)
reveals a root-mean-square deviation (rmsd) betweenby a hydrogen bond between Asp18 and Trp96. Helices
1a and 2 are nearly parallel to each other and, with parts C atoms of between 0.33 A˚ for the closely similar mono-
mers 1 and 2 and 0.71 A˚ for the least similar monomersof the 310 helical loop (Figure 2B), may comprise the
membrane binding site of M-MuLV MA, since a number 2 and 3 (Table 2). These differences are principally due
to discrepancies at the C- and N-terminal ends. Theof basic residues (Lys 31, Lys 32, Arg 33, and Arg 34)
cluster in this region (Figure 2C). In electrostatic terms, length of chain for which there is clear electron density
Structure of M-MuLV Matrix Protein
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Figure 1. Crystallography
(A) A stereo view of the 2Fo  Fc 1 A˚ electron density map contoured at 2  shown as a cyan mesh with the MLV model superimposed as a
red ball and stick model.
(B) The M-MuLV P1 asymmetric unit showing the more and less precise 2-fold relationships. Monomers 1 and 2 are depicted as ribbons in
red and blue, respectively, and monomers 3 and 4 are depicted as ribbons in yellow and green, respectively.
(C) A superimposition of the four monomers in worm representation, color-coded as in (B). The view is approximately derived by a 90	 rotation
of subunit 4 of (B) about a vertical axis in the plane of the paper.
The figures were generated with BOBSCRIPT [44] and Raster3D [45].
varies between 93 (monomer 2) and 98 residues (mono- Structural Correlates of Mutagenesis Studies
N-myristoyl transferase (NMT) recognizes a particularmer 4) out of a possible 100 residues in the truncated
M-MuLV construct. Except where otherwise stated the sequence motif that includes Val5 and Thr6 of M-MuLV
MA, as expected mutations in these residues were foundstructural features located on Figure 2B are found in all
four monomers, and the enumeration of the amino acids to reduce virus titer and RT activity because of improper
myristoylation [28]. The important role of the first eightis as the natural sequence. However, the contacts stabi-
lizing this arrangement vary between the dimers. Thus, residues in myristoylation is in accord with their very
exposed positions. Further, mutants with alterations inthe dimer comprising monomers 1 and 2 is stabilized
by interactions involving the loop between helices 1b residues 7–14 (helix 1a) were found to be replication
defective [29], and mutation of Leu 11 [28] was foundand 2 and the N terminus of helix 4, while monomers 3
and 4 interact via helix 1b. Thus, residues at the end of to substantially reduce titre. Helix 1a may form part of
the membrane binding site, but we cannot say if it hashelix 1b are common to both interactions: Gln26, Ser27,




(A) Stereo C trace of M-MuLV monomer 4,
colored from blue to yellow from the N to the
C terminus. Every tenth residue is labeled.
The view is the same as that in Figure 1C.
(B) Ribbon diagrams of M-MuLV monomer 4
and HIV-1 [19] showing the similarity in dispo-
sition of the helices. The coloring is from blue
to yellow in M-MuLV and from blue to red in
HIV-1, and the helices are labeled. The view
is the same as that in Figure 1C.
(C) The proposed membrane binding surface
of the M-MuLV MA monomer comprising heli-
ces 1a and 2 and the N terminus. Alongside is
a GRASP [49] electrostatic depiction showing
the basic patch on this surface. The electro-
static potential is colored such that positive
charge is shown in blue and the negative
charge is shown in red.
The figures were generated with BOBSCRIPT
[44] and Raster3D [45].
Trp35, Trp43, and Trp50 seem to play an important helix 2, exactly in the position that we believe is pre-
sented to the plasma membrane (Figure 2), enhancingrole in the dense packing and stabilization of the protein
core. Mutations in these tryptophans produced Gag pro- the protein-membrane interaction. It therefore supports
the proposal that MA binding to the plasma membraneteins, which were, despite having normal myristoylation,
localized around the nucleus in a diffuse manner. Futher- is mediated by both myristoylation and basic residues
presented on the surface.more, these mutants were not infective and showed no
significant reverse transcriptase (RT) activity [28]. From
the three-dimensional structure, we can see that stag- Structural Correlations and Differences
to Other MA Proteinsgering of the aromatic residues is crucial for stable MA
formation, and mutations must therefore lead to misfold- M-MuLV has a low sequence identity compared with
other matrix proteins for which the three-dimensionaling of MA or even the entire Gag polyprotein, thus having
a deleterious effect on early postentry steps. structure is known, although it does share with BLV and
HTLV-2 an enrichment in prolines (24 of 137 residuesMutations in the N-terminal basic residues (K17N,
R21Q, K31E, K32N, R33E, and R34N) have been re- overall, 16 of 38 C-terminal residues). Interestingly its
overall topology and pattern of secondary-structuralported [28] to inhibit translocation of MA to the mem-
brane. Residues 31–34 are located at the beginning of units is similar to other retroviral matrix proteins [30]
Structure of M-MuLV Matrix Protein
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Table 2. Refinement (Data Set N-2)
Resolution range (A˚) 20–1.0
Number of unique reflections 141,625
R factor (%)a 13.3
Rfree (%) 16.9
Protein model 3167 atoms (monomer 1, 96 residues [3–98]; monomer 2, 93 residues [6–98]; monomer 3,
94 residues [5–98]; monomer 4, 97 residues [2–98])
Number of disordered side chains monomer 1, 7; monomer 2, 6; monomer 3, 5; monomer 4, 7
Solvent 569
Rmsd bond lengths (A˚)b 0.016
Rmsd angles (	)b 2.5
Rmsd B (main chain; A˚2)c monomer 1, 1.2; monomer 2, 1.1; monomer 3, 1.2; monomer 4, 1.1
Rmsd B (side chain; A˚2)c monomer 1, 2.8; monomer 2, 2.6; monomer 3, 3.0; monomer 4, 3.0
Mean overall B factor (A˚2) monomer 1, 13.2; monomer 2, 12.4; monomer 3, 14.8; monomer 4, 13.2
The values shown in parentheses are for the highest resolution shell.
a R  100  h||Fh,obs|  |Fh,calc||/h|Fh,obs|.
b Root-mean-square deviation from ideal bond lengths or bond angles.
c Root-mean-square deviation of B factors for main chain and side chain, respectively.
(Figure 2B), yet secondary-structure prediction pro- and 1b) in M-MuLV correspond to the first helix and part
of the first loop in the lentiviral MAs (SIV, HIV-1, and EIAV).grams could not detect this. We believe that this is a
powerful argument for the biological relevance of the In common with HTLV-2 [25], MPMV [26], and RSV,
M-MuLV has no fifth helix (Figures 2B and 3). However,largely helical arrangement that characterizes these pro-
teins. Table 3 shows the results of a structural superim- our structure is of the C-terminally truncated protein
and is 9, 19, and 21 residues shorter than the EIAV, SIV,position of the M-MuLV structure with related proteins,
performed with SHP ([31] and unpublished data). The and HIV-1 matrix protein structures, respectively, and
the conformation of the C-terminal residues is unknownarrangement of  helices is largely maintained (Figures
2B and 3); helix 4 is particularly well conserved as are, (although the high proline content would argue against
an extended helix, and the hindrance we have observedto a large extent, helices 2 and 3. The mixed 
 sheet in
HIV-1 and SIV is not conserved. The first two helices (1a it to impose on crystallization suggests some flexibility).
Table 3. Structural Comparison of Matrix Proteins
HIV-1 (NMR)c HIV-1 (NMR)d HIV-1 (X-Ray)e SIVf EIAVh M-PMVk RSV M Domainj HTLV-IIg,l
MA Protein (1TAM) (2HMX) (1HIW) (1ED1) (1HEK) M-MuLV (1BAX) (1A6S) BLVi (1JVR)
HIV-1 (NMR)c 32.3b 34.8 36.0 27.5 22.2 18.7 18.2 14.9 13.8
(1TAM)a
HIV-1 (NMR)d 36.0 34.9 30.9 17.8 20.9 17.1 13.1 14.8
(2HMX)
HIV-1 (X-ray)e 35.4 24.0 19.6 14.8 15.0 12.4 12.5
(1HIW)
SIVf 23.0 17.8 17.9 15.5 12.2 12.7
(1ED1)
EIAVh 18.5 15.7 16.0 14.9 13.0
(1HEK)
M-MuLV 18.9 16.8 18.3 13.4
M-PMVk 17.4 19.8 19.5
(1BAX)
RSV M Domainj 18.5 17.3
(1A6S)
BLVi 18.6
a Protein Data Bank accession code of the Research Collaboratory for Structural Bioinformatics (RCSB) [52].
b Summed structural correlation, total probabilities calculated from a superimposition with the program SHP [31].
c,d,e HIV-1, human immunodeficiency virus type 1, NMR and X-RAY structures, respectively [19, 21, 50].
f SIV, simian immunodeficiency virus at 100 K. [18].
g HTLV-II, human T-cell leukemia virus type 2 [25].
h EIAV, equine infectious anemia virus [22].
i BLV, bovine leukemia virus [26].
j RSV, Rous sarcoma virus [23].
k M-PMV, Mason-Pfizer monkey virus [24].
l A truncated version (residues 2–91) has been used for calculations.
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Figure 3. Structure Analysis
(A) Superimposition of M-MuLV (green) with
the HIV-1 crystal structure [19] (yellow) and
the HIV-1 NMR structure [50] (cyan).
(B) Superimposition of M-MuLV (green) with
the other lentivirus matrix protein crystal
structures: EIAV [22] (pink) and SIV [18] (lilac).
(C) Superimposition of M-MuLV (green) with
BLV [26] (blue) and HTLV [25] (red).
(D) Superimposition of M-MuLV (green) with
MPMV [24] (magenta) and RSV [23] (orange).
The C terminus of helix 1b in M-MuLV occupies the some variation in the first and fifth helices, which facili-
tate intermolecular interactions, may be accommodated.position of the N terminus of helix 5 in the proteins where
it exists, and the loop linking helices 1b and 2 are some A minor conformational rearrangement could convert
the first two helices in M-MuLV MA into an extendedfive to six residues shorter in M-MuLV than in HIV-1,
SIV, and EIAV, making M-MuLV matrix protein slightly first helix similar to that found in the other structures.
The overall surface area of the truncated M-MuLV ismore compact. Thus, the conserved helices 2, 3, and 4
appear crucial to the integrity of the molecule, while 5880 A˚3 as compared with 7360 A˚3 for HIV-1 [19].
Structure of M-MuLV Matrix Protein
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Figure 4. Evolution
(A) A structure-based sequence alignment prepared with pairwise superimpositions [31], multiple alignment (Clustal W [51]), and ESPript [46].
The bar at the bottom displays the relative accessibility of each residue, as calculated by DSSP [47]. Blue indicates an accessible residue,
cyan indicates a residue with intermediate accessibility, and white indicates a buried residue.
(B) A phylogenetic tree for retroviral matrix proteins based solely on structural comparison. The tree was prepared with PHYLIP [48] with the
data in Table 3 to construct a distance matrix.
A 310 helix found at the end of helix 2 corresponds to nization of the molecules exists, since the four proteins
that make up one crystallographic asymmetric unit as-the start of the 310-helical loop observed in SIV, HIV-1,
and EIAV (Figure 2). Overall this loop has a similar length, sociate as dimers/pseudodimers. Some of the interac-
tions between M-MuLV monomers are more extensivebut is partly unfolded, in M-MuLV. The loop between
helices 3 and 4 is three residues shorter in M-MuLV than those seen between monomers in the HIV-1 trimeric
association (a total of 1880 A˚2 of buried surface area(owing to the N-terminal extension of helix 4 by a short
stretch of 310 helix). This loop is nonetheless quite a [19]). As to a possible biological relevance for these
dimeric associations, we cannot speculate; however,prominent feature, and its conformation may be con-
trolled by prolines 71 and 73. Overall the prolines clearly the residues common to both dimer interfaces do not
appear to be conserved. M-MuLV is clearly very poly-have a role in stabilizing the structural elements, as
reported for BLV MA [26], although different residues morphic in the way that it forms lateral interactions, so
we cannot discount the possibility that M-MuLV MAmay obviously fulfill the same function, e.g., in HIV-1 MA.
None of the matrix proteins contain disulphide bonds. could also, with minor conformational rearrangements,
associate in a trimeric way in the mature capsid. Al-In the HIV-1 and SIV MA crystal structures [18, 19], a
trimeric molecular organization was observed. This was though we have studied a C-terminally truncated pro-
tein, the analogous extension was not involved in tri-hypothesized to correspond to an assembly intermedi-
ate of the Gag shell presenting a bipartite membrane meric contacts in HIV-1 [19] or SIV [18]. The trimer
interactions in these structures were also largely attrib-binding surface and to be in agreement with the symme-
try of the structure predicted by electron microscopy utable to main chain atoms; thus, variation in sequence
at these positions should not affect the capacity to tri-[32]. In this model, exposed basic residues are assumed
to cooperate with the N-terminal myristoyl groups to merize. Another matrix protein, that of EIAV, did not
associate as a trimer in the crystal structure [22]. Tableanchor the protein to the inner anionic leaflet of the
membrane [33]. In the M-MuLV crystals no trimeric orga- 3 provides a quantitative measure of the similarity be-
Structure
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tween matrix proteins on the basis of a structural super- these play an important role, partly through imposing
structural constraints and also, possibly, by allowingimposition [31]. It can be seen that M-MuLV appears
most similar to the monomeric HIV-1 NMR coordinates switching between conformational states by isomer-
ization.[21], suggesting that it could share the capacity for tri-
merization. Indeed M-MuLV matrix protein would appear The conservation of core side chain volumes deserves
further analysis, as it may provide useful constraintsfrom this analysis to be marginally most similar to HIV-1,
SIV, and EIAV. M-MuLV was originally classified (on the when searching for distant relationships between pro-
teins. Our structural analysis of this Gammaretrovirusbasis of morphology) as a C-type retrovirus together
with these other viruses, although separated into a dis- MA protein reveals its intermediate similarity to the len-
tiviral and other orthoretroviral MAs. This may help de-tinct subfamily on the basis of pathogenicity.
It appears that hydrophobic interactions are primarily fine the evolutionary relationships of these viruses,
which have previously been based on amino acid se-responsible for the conservation of topology within this
family of proteins. Analysis of the superimposed struc- quence similarities in the RT protein. In summary, the
core structure of retroviral MA is clearly essential fortures reveals certain side chain volumes that are neces-
sarily occupied, with no restriction on the residue type biological function, although the full functional load car-
ried by the protein remains unclear.or sequence position. The volumes that are conserved
across M-MuLV, EIAV, HIV-1, BLV, and RSV correspond
to M-MuLV side chains W50, W86, F56, W43, and F38 Experimental Procedures
and HIV-1 [19] L51, L85, H89, I82, and W36, respectively,
Protein Expression and Purificationwhile other side chain volumes are shared between dif-
The protein coding sequence was derived from the matrix proteinferent subsets of the matrix proteins.
of ecotropic Moloney murine leukemia virus (M-MuLV p15). Crystals
of the full-length protein diffracted only poorly. On the basis of a
three-dimensional structure prediction [34] and the results of Jor-MA Structure-Based Quantitative Phylogeny
gensen et al. [35], who studied mutants with successive in-frameThe systematic comparison of the MA three-dimen-
deletions suggesting that the C-terminal 27 amino acids are notsional structures summarized in Table 3 and Figure 4A
essential for the assembly of MuLV, a C-terminal truncation terminat-
has been used as the basis for establishing method- ing after Pro 99 was engineered. The truncated protein (t-M-MuLV)
corrected (see Experimental Procedures) phylogenetic was expressed with a pET32a plasmid (NOVAGEN) in E. coli, strain
distance data from the superpositions for the construc- BL21 (D3), and, as a consequence of the expression design, an
extra alanine was incorporated prior to the first natural methionine.tion of a structure-based phylogenetic tree (Figure 4B).
After purification from the bacterial lysate with His-Bind resin (NO-This reveals the intermediate similarity of M-MuLV MA
VAGEN), the t-M-MuLV p15 was cleaved with recombinant enteroki-between lentiviral and other retroviral MAs. We suggest
nase. The cleavage product was further purified with a Mono-S
that such methods will provide a powerful tool for objec- column (Pharmacia) with a 0–600 mM NaCl gradient in 50 mM Tris-
tive phylogenetic analysis when correspondance has HCL (pH 8.0) and then dialyzed against water.
been lost from the primary sequence data.
Crystallization
The crystals were grown at room temperature by the sitting dropBiological Implications
vapor diffusion method [36]. Typically, 1 l of precipitant was added
to 3 l of protein solution (at 3 mg/ml). The precipitant/reservoir
The Gammaretrovirus M-MuLV matrix protein has little solution consisted of Hampton Research Crystal Screen 1 Reagent
sequence identity with other retroviral matrix proteins, # 38 (0.1 M HEPES-Na [pH 7.5] and 1.4 M sodium citrate) and 100
yet its structure is remarkably conserved and supports mM NaCl. Protein clusters formed within a day. After 2–3 weeks, single
crystals emerged from these accumulations, in some of the drops.most of the hypotheses made on the basis of other
Four heavy-atom derivatives were used for the structure determi-retroviral MAs [18, 19].
nation (Table 2).The structure, a wedge-shaped, helical bundle (which
may facilitate budding), has dimensions commensurate
Data Collectionwith other matrix proteins and a basic surface patch likely,
Data were collected at 100 K with a cryostream (Oxford Cryosys-with the extended naturally myristylated N terminus, to
tems). Crystals were briefly transferred into a solution containinginteract with the phospholipid headgroups in the mem-
reservoir solution and 10% (v/v) glycerol prior to freezing in the
brane. This orientation agrees with models derived from stream of cold nitrogen gas.
the trimeric SIV and HIV-1 structures. While the polymor- Two native data sets were taken. (1) N-1 was taken at beamline
ID 14.4 at the European Synchrotron Radiation Facility (ESRF) inphic nature of the lateral interactions in the crystal does
Grenoble. The data were collected at a wavelength of 0.9777 A˚ withnot provide direct evidence for an oligomerization state
an ADSC Q4R CCD detector. (2) N-2 was taken at the (SRS) inrelevant to particle formation, it does not preclude an
Daresbury with beamline PX 14.2. The data were collected at aHIV/SIV-type trimeric interaction. This polymorphism
wavelength of 0.978 A˚ with an ADSC Q4R CCD detector.
may reflect the different interactions required in the im- Heavy-atom derivative data sets for EMP, mHg, and HgI, were all
mature and mature particle. The structural elements that collected in house (wavelength 1.5418 A˚ [Cu K] with a 300 mm
diameter mar research [Hamburg, Germany] imaging plate detector),contribute most to the molecular stability are particularly
except for the PtCl data set, which was collected at the same wave-well conserved. There is a striking staggering of large
length with a mar345 image plate detector (mar research).hydrophobic residues in the protein core. The presence
Data were processed with the programs DENZO and SCALEPACKof a “greasy core” may confer extra tolerance to shear
[37]. Further crystallographic computations were performed with
forces, which may be particularly relevant to the stresses programs from the CCP4 suite [38], except where noted. The crystals
of conformational changes in maturation. In addition the belong to space group P1, with unit cell dimensions of a  33.8 A˚,
b  49.5 A˚, c  50.8 A˚,   71.9	, 
  81.9	, and   80.0	.above average use of prolines in M-MuLV suggests that
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Crystal Structure Determination 3. Rein, A., McClure, M.R., Rice, N.R., Luftig, R.B., and Schultz,
A.M. (1986). Myristylation site in Pr65gag is essential for virusA self-rotation function was calculated with CNS [39] with data in
the range from 20 to 4 A˚. Patterson vector lengths in the range from particle formation by Moloney murine leukemia virus. Proc. Natl.
Acad. Sci. USA 83, 7246–7250.7 to 25 A˚ were selected. A top peak was obtained at   180	 ( 
1.86), indicative of 2-fold noncrystallographic symmetry. Mercury 4. Facke, M., Janetzko, A., Shoeman, R.L., and Krausslich, H.G.
(1993). A large deletion in the matrix domain of the human immu-and platinum sites were identified in Patterson and difference Fou-
rier maps and used with the first native data set in SHARP [40] for nodeficiency virus gag gene redirects virus particle assembly
from the plasma membrane to the endoplasmic reticulum. J.phase calculation, leading to a final figure of merit of 0.55 at 2.0 A˚.
Solvent flattening and averaging with the program GAP (D.I.S. and Virol. 67, 4972–4980.
5. Hunter, E. (1994). Macromolecular interactions in the assemblyJ. Grimes, unpublished data) produced an experimental map of
good quality. of HIV and other retroviuses. Semin. Virol. 5, 71–83.
6. Wills, J.W., and Craven, R.C. (1991). Form, function and use ofFour protein molecules were found in each asymmetric unit, and
the first model was built by hand with the program O [41]. retroviral Gag proteins. AIDS 5, 639–654.
7. Wilk, T., Gross, I., Gowen, B.E., Rutten, T., de Haas, F., Welker,
R., Krausslich, H.G., Boulanger, P., and Fuller, S.D. (2001). Orga-Refinement
nization of immature human immunodeficiency virus. J. Virol.Refinement was performed initially against data set N-1 with CNS
75, 759–771.[39] and manual rebuilding in O. When the R factor reached 0.24,
8. Dorfman, T., Mammano, F., Haseltine, W.A., and Gottlinger, H.G.the model was adjusted to data set N-2 with rigid body refinement
(1994). Role of the matrix protein in the virion association of thein CNS. Further iterative refinement led to an R factor of 0.198 at
human immunodeficiency virus type 1 envelope glycoprotein.1.0 A˚ resolution. After switching to SHELX [42] and the introduction
J. Virol. 68, 1689–1696.of individual anisotropic B factors, disordered side chains, hydro-
9. Freed, E.O., and Martin, M.A. (1995). Virion incorporation ofgens, and 568 water molecules, a final R factor of 13.3% (Rfree 
envelope glycoproteins with long but not short cytoplasmic tails16.9%) was obtained. Because of the lack of defined density, a total
is blocked by specific, single amino acid substitutions in theof 24 residues (5.9 %) were omitted from the four monomers.
human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984–A number of criteria establish the correctness of the structure. (1)
1989.The experimental electron density map is of high quality and accords
10. Yu, X., Yuan, X., Matsuda, Z., Lee, T.H., and Essex, M. (1992).with the model. (2) A total of 92.2 % of all the nonproline and nongly-
The matrix protein of human immunodeficiency virus type 1 iscine residues in the asymmetric unit have  and  angles in the
required for incorporation of viral envelope protein into maturemost favored regions, and 7.8 % have  and  angles in the addi-
virions. J. Virol. 66, 4966–4971.tional allowed regions of the Ramachandran plot; no residues were
11. Yu, X., Yu, Q.C., Lee, T.H., and Essex, M. (1992). The C terminusin disallowed regions [43].
of human immunodeficiency virus type 1 matrix protein is in-M-MuLV has a below average percentage of discretely disordered
volved in early steps of the virus life cycle. J. Virol. 66, 5667–residues compared with other structures at equally high resolution,
5670.indicating that the structure is quite stable.
12. Bukrinsky, M.I., Haggerty, S., Dempsey, M.P., Sharova, N., Ad-
zhubel, A., Spitz, L., Lewis, P., Goldfarb, D., Emerman, M., andStructural Analysis/Display
Stevenson, M. (1993). A nuclear localization signal within HIV-1Surface area calculations were performed with the CCP4 package
matrix protein that governs infection of non-dividing cells. Na-(program Surface) [38]. Structural depictions were produced with
ture 365, 666–669.Bobscript [44], Raster3D [45], and Photoshop.
13. Gallay, P., Stitt, V., Mundy, C., Oettinger, M., and Trono, D.
(1996). Role of the karypopherin pathway in human immunodefi-
Structural Comparison ciency virus type 1 matrix. J. Virol. 69, 1984–1989.
Structural comparisons were performed with SHP [31] and O [41]. 14. Gallay, P., Swingler, S., Aiken, C., and Trono, D. (1995). HIV-1
Modifications were made to the SHP program to include in the infection of nondividing cells: C-terminal tyrosine phosphoryla-
probability calculation gap penalties and the likely experimental tion of the viral matrix protein is a key regulator. Cell 80, 379–388.
error in the structure (this was assumed to be greater for NMR 15. Gallay, P., Swingler, S., Song, J., Bushman, F., and Trono, D.
structures than for high-resolution X-ray structures) (D.I.S., unpub- (1995). HIV nuclear import is governed by the phosphotyrosine-
lished data). Superimposed secondary structure elements were then mediated binding of matrix to the core domain of integrase. Cell
used for sequence alignment studies. Sequence similarities were 83, 569–576.
thus determined by tertiary structure matching, rather than by se- 16. von Schwedler, U., Kornbluth, R.S., and Trono, D. (1994). The
quence homology. The final sequence evaluation was created with nuclear localization signal of the matrix protein of human immu-
ESPript 1.9 [46], with relative accessibilities assigned by DSSP [47]. nodeficiency virus type 1 allows the establishment of infection
The summed probabilities obtained by structural comparison (Table in macrophages and quiescent T lymphocytes. Proc. Natl. Acad.
3) were converted to a phylogenetic distance as the ln (total proba- Sci. USA 91, 6992–6996.
bility for a pairwise match/number of residues in the shortest of 17. Morikawa, Y., Kishi, T., Zhang, W.H., Nermut, M.V., Hockley,
the two sequences). A phylogenetic tree was constructed from the D.J., and Jones, I.M. (1995). A molecular determinant of human
resultant distance matrix with the PHYLIP package [48]. immunodeficiency virus particle assembly located in matrix anti-
gen p17. J. Virol. 69, 4519–4523.
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